BioPacific Conference 2013 Agenda
Theme: Thriving in a Challenging Time 迎接挑战， 蓬勃发展
May 11, 2013, Crown Plaza Hotel, Foster City, CA, USA
| 8:00 – 9:00 am | Registration and Vendor Exhibition |
| 9:00 – 9:05 am | Welcome Remarks Zhonghua Pei, Ph.D., CABS President-Elect, BioPacific Organizing Committee Chair |
| 9:05 – 9:15 am | State of the Society Wentao Zhang, , Ph.D., President of CABS |
| 9:15 – 10:30 am | Successful Stories & Case Studies of Innovative New Medicine
Session chairpersons: Charlene Liao, Shichang Miao & Jessica Sun |
| 9:15 – 9:40 am | Mark Sliwkowski, Ph.D., Distinguished Staff Scientist, Genentech “Multiple Approaches to Targeting HER/ErbB Receptors in Solid Tumors” |
| 9:40 – 10.05 am | Christopher Kirk, Ph.D., Vice President of Research, Onyx “Towards optimized utility of proteasome inhibitors with peptide epoxyketones” |
| 10:05 – 10.30 am | Charles Hart, Ph.D., Vice President of Biology, Threshold “Selective Targeting of Hypoxic Cancer Cells with the Hypoxia-Activated Prodrug TH-302: Preclinical and Clinical Studies” |
| 10:30 – 10:55 am | Break, Vendor Exhibition & Networking |
| 10:55 – 11:10 am | CABS K. Fong Award in Life Sciences
Session chairperson: Wentao Zhang |
| 11:10 – 11:30 am | Special topic Session chairperson: Zhonghua Pei Jing Huang, Ph.D., Director-General of China National Center for Biotechnology Development (CNCBD),Ministry of Science & Technology (MOST) of P.R. China |
| 11:30 – 12:40 am | Genomics & Personalized Medicine
Session chairpersons: Jiangwen Majeti, Sophie Liu & Janet Xiao |
| 11:30 – 11:55 pm | Stephen Quake, Professor, Stanford University; Investigator, Howard Hughes Medical Institute (HHMI) “Single Cell and Single Molecule Genomics” |
| 11:55 – 12:20 pm | Radoje Drmanac, Ph.D., Chief Scientific Officer, Complete Genomics “Accurate whole genome sequencing as the ultimate genetic test enabling personalized disease prevention and treatment” |
| 11:55 – 12:20 pm | Jie Zhou, Ph.D., Partner, Morison-Foerster “Patent protection for personalized medicine inventions” |
| 12:40 – 1:40 pm | Lunch |
| 1:40 – 3:15 pm | Drug Discovery & Development, Leveraging China-US Collaboration |
| 1:40 – 2:00 pm | Ruiping Dong, Ph.D., Senior VP of R&D of Emerging Market, Merck. “Multi-national Center R&D in China” |
| 2:00 – 2:20 pm | Thomas L. Irving, Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP “What Innovative Chinese Companies Need to Know to Obtain Strong U.S. Patent Portfolios” |
| 2:20 – 2:40 pm | Richard Soll, Ph.D., SVP, WuXi AppTec “Accelerating Innovation in a Collaborative Biopharma Ecosystem” |
| 2:40 – 3:05 pm | Gold Sponsor Presentations Jeff Moran, Director of Business Development, QPS LLC Connie Sun, Ph.D., SVP, Sr. Vice President, Pharmaron Bin Li, CEO, Health-coming |
| 3:05 – 3:35 pm | Break: Vendor Exhibition & Networking |
| 3:35 – 5:00 pm | Entrepreneurship & Emerging Market
Session chairpersons: Cheni Kwok, Carrie Wang & Jianlong Lou |
| 3:35 – 3:55 pm | Neeraj Kumar, Centre Director (Western Americas), Economic Development Board of Singapore “Singapore – The Biopolis of Asia” |
| 3:55 – 4:15 pm | Jonathan Norris, Managing Director, SVB Capital “Life Science Venture Overview” |
| 4:15 – 4:30 pm | Gold Sponsor Presentations Chen Chen, Ph.D., CEO, Sundia Ray Zhang, Director of Business Promotion & Portfolio, Simcere Pharmaceutical, China |
| 4:30 – 5:00 pm | Corey Goodman, Ph.D., Partner, VenBio “Building Successful Biotech Companies in a Challenging Environment” |
| 5:00 – 5:20 pm | Dinner Setup |
| 5:20 – 6:30 pm | Dinner |
| 6:30 -8:30 pm | Panel discussion: The journey of Biotech entrepreneurship, From bench to business. Moderator: Xiaoli Qin Panelists: • Jay Tong, M.D., Founder, President & CEO, AllCells, LLC |
| 8:30 pm | Conference Adjourned |
 |
|